Revascularization in severe left ventricular dysfunction - The role of viability testing

被引:82
作者
Chareonthaitawee, P
Gersh, BJ
Araoz, PA
Gibbons, RJ
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Radiol, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.jacc.2005.03.072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy. (C) 2005 by the American College of Cardiology Foundation
引用
收藏
页码:567 / 574
页数:8
相关论文
共 53 条
[11]  
Beanlands RSB, 1998, CIRCULATION, V98, pII51
[12]  
BOUNOUS EP, 1988, CIRCULATION, V78, P151
[13]   Comparison of left ventriculography and coronary arteriography with positron emission tomography in assessment of myocardial viability [J].
Bourdillon, PDV ;
Von der Lohe, E ;
Lewis, SJ ;
Sharifi, M ;
Burt, RW ;
Sawada, SG .
CLINICAL CARDIOLOGY, 2003, 26 (02) :60-66
[14]   Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: A meta-analysis [J].
Bourque, JM ;
Hasselblad, V ;
Velazquez, EJ ;
Borges-Neto, S ;
O'Connor, CM .
AMERICAN HEART JOURNAL, 2003, 146 (04) :621-627
[15]   Radionuclide viability testing: Should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? [J].
Bourque, JM ;
Velazquez, EJ ;
Borges-Neto, S ;
Shaw, LK ;
Whellan, DJ ;
O'Connor, CM .
AMERICAN HEART JOURNAL, 2003, 145 (05) :758-767
[16]   POSITRON EMISSION TOMOGRAPHY DETECTS METABOLIC VIABILITY IN MYOCARDIUM WITH PERSISTENT 24-HOUR SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY TL-201 DEFECTS [J].
BRUNKEN, RC ;
MODY, FV ;
HAWKINS, RA ;
NIENABER, C ;
PHELPS, ME ;
SCHELBERT, HR .
CIRCULATION, 1992, 86 (05) :1357-1369
[17]   Hibernating myocardium - Chronically adapted to ischemia but vulnerable to sudden death [J].
Canty, JM ;
Suzuki, G ;
Banas, MD ;
Verheyen, F ;
Borgers, M ;
Fallavollita, JA .
CIRCULATION RESEARCH, 2004, 94 (08) :1142-1149
[18]   Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial [J].
Cleland, JGF ;
Pennell, DJ ;
Ray, SG ;
Coats, AJ ;
Macfarlane, PW ;
Murray, GD ;
Mule, JD ;
Vered, Z ;
Lahiri, A .
LANCET, 2003, 362 (9377) :14-21
[19]   The heart failure revascularisation trial (HEART): rationale, design and methodology [J].
Cleland, JGF ;
Freemantle, N ;
Ball, SG ;
Bonser, RS ;
Camici, P ;
Chattopadhyay, S ;
Dutka, D ;
Eastaugh, J ;
Hampton, J ;
Large, S ;
Norell, MS ;
Pennell, DJ ;
Pepper, J ;
Sanda, S ;
Senior, R ;
Smith, D .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (03) :295-303
[20]   5-YEAR EFFECT OF MEDICAL AND SURGICAL THERAPY ON RESTING LEFT-VENTRICULAR FUNCTION IN STABLE ANGINA - VETERANS-ADMINISTRATION-COOPERATIVE-STUDY [J].
DETRE, KM ;
PEDUZZI, P ;
HAMMERMEISTER, KE ;
MURPHY, ML ;
HULTGREN, HN ;
TAKARO, T .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (04) :444-450